| BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes (NCT07628985) | Carnot Laboratories | 2026-09-01 |
| Rollover Study for Participants Who Have Completed a Previous Clinical Study With Anifrolumab (Saphnelo) and Clinically Benefited From Continued Treatment (NCT07691970) | AstraZeneca | 2026-09-01 |
| Paclitaxel and Pegylated Liposomal Doxorubicin for Treatment of HIV-related Kaposi Sarcoma (NCT05411237) | AIDS Malignancy Consortium | 2026-09-01 |
| An Open-label Study to Assess the Safety and Efficacy of SYMVESS® as a Vascular Conduit in Adolescents With Extremity Arterial Injury. (NCT07762313) | Humacyte, Inc. | 2026-09-01 |
| Effectiveness Trial of an mHealth Intervention to Help Parents Prevent Early Onset Alcohol Use (NCT07683702) | RTI International | 2026-09-01 |
| Building Adaptive School-based Interventions for Caries (NCT07265830) | University of Pennsylvania | 2026-09-01 |
| A Study of Orforglipron (LY3502970) Compared With Dulaglutide in Pediatric Participants With Type 2 Diabetes (NCT07668336) | Eli Lilly and Company | 2026-09-01 |
| Adjuvant Trial in Pancreatic Neuroendocrine Tumors (NCT07591493) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-09-01 |
| Study to Evaluate the Efficacy and Safety of Ponesimod (VSP-128) in Patients With Moderately to Severely Active Ulcerative Colitis (NCT07686081) | Vanda Pharmaceuticals | 2026-09-01 |
| A Combination of Antibiotics to Decrease Neonatal Morbidity and Mortality for Previable Threatened Labor (NCT06572761) | Assistance Publique - Hôpitaux de Paris | 2026-09-01 |
| Efficacy of the Alpha 2 Agonist Dexmedetomidine for Sympathetic Deactivation in REfractory Septic Shock (NCT07569536) | Hospices Civils de Lyon | 2026-09-01 |
| A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With α- or β-Non-Transfusion-Dependent Thalassemia (NCT07517133) | Agios Pharmaceuticals, Inc. | 2026-09-01 |
| Effectiveness of Single and Dual Silver Fluoride Application (NCT07658690) | University of Malaya | 2026-09-01 |
| A Study Investigating Intravenous Human Normal Immune Globulin 10% in Adults With Stiff Person Syndrome (NCT07552987) | Kedrion S.p.A. | 2026-09-01 |
| A Randomized, Double-Blind Controlled Comparison of NRX-101 vs. Placebo for Adults Being Treated With Robotic Transcranial Magnetic Stimulation for Treatment Resistant Depression: The SPARC-TMS Trial (NCT07227103) | NeuroRx, Inc. | 2026-09-01 |
| Effects, Metabolic Mechanisms and Predictors of Response to Acupuncture in Treating Psychoneurological Symptoms Among Breast Cancer Survivors (NCT07695948) | University of Illinois at Chicago | 2026-09-01 |
| Morphine or Ketamine for Analgesia (NCT06835504) | Columbia University | 2026-09-01 |
| Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal Adenocarcinoma (NCT07763171) | Gruppo Oncologico del Nord-Ovest | 2026-09-01 |
| A Clinical Study of QL1706 Combined With Chemotherapy as Neoadjuvant Therapy for High-Risk Locally Advanced Cervical Cancer (NCT07613567) | Fujian Cancer Hospital | 2026-09-01 |
| Naproxen Versus Placebo as Adjunct Treatment of Cellulitis (NCT07665476) | Ottawa Hospital Research Institute | 2026-09-01 |
| Carboplatin-Enhanced Therapy in BRCA-Mutated or Neuroendocrine-Differentiated Aggressive Metastatic Castration-Sensitive Prostate Cancer (NCT07591467) | Gustave Roussy, Cancer Campus, Grand Paris | 2026-09-01 |
| Glenzocimab in Anterior Stroke With Large Ischemic Core Eligible for Endovascular Therapy (NCT06437431) | Fondation Ophtalmologique Adolphe de Rothschild | 2026-09-01 |
| Optimizing Care for Cryptococcal Antigenemia: Evaluation of Short Course Fluconazole and ART Timing Among CrAg+ Persons With Low Titers (NCT07743593) | University of Minnesota | 2026-09-01 |
| Normobaric Hyperoxia With Extended-Window Endovascular Therapy for Acute Ischemic Stroke (OPENS-EXTEND) (NCT07717216) | Weifang Medical University | 2026-09-01 |
| Safety and Tolerability of IRX-101 in Patients Receiving Intravitreal Injections (NCT05750589) | iRenix Medical, Inc. | 2026-09-01 |
| Impact of Prophylactic Bone Radiation Therapy in Patients With Bone Metastases. (NCT07733193) | Centre Henri Becquerel | 2026-09-01 |
| Double-Blind Trial of Everolimus for Improving Social Abilities in PTEN Germline Mutations (NCT07218575) | Boston Children's Hospital | 2026-09-01 |
| Efficacy and Safety of VER-01 in the Treatment of Participants With Chronic Painful Lumbosacral Radiculopathy (NCT06956014) | Vertanical GmbH | 2026-09-01 |
| Echo-guided Scalp Blocks and Incidence of Postoperative Pain in Scheduled Supratentorial Intracranial Surgery. (NCT07149077) | University Hospital, Bordeaux | 2026-09-01 |
| A Study Comparing Treatment With Teclistamab and Talquetamab Versus Daratumumab and Lenalidomide in Patients With Multiple Myeloma After Stem Cell Transplant Who Still Have Detectable Disease (NCT07740486) | Polish Myeloma Consortium | 2026-09-01 |
| Study of Fluticasone/Formoterol/Glycopyrronium for the Treatment Chronic Obstructive Pulmonary Disease (TRIPLAR) (NCT06234345) | Eurofarma Laboratorios S.A. | 2026-09-01 |
| IVIG Boya: Safety, Efficacy, and Pharmacokinetics (NCT06150833) | Azidus Brasil | 2026-09-01 |
| Evaluation of the Efficacy of Iloprost in the Management of Vaso-occlusive Crises in Adult Patients With Sickle Cell Disease (NCT07498309) | University Hospital, Rouen | 2026-09-01 |
| BALANCE-OBS: Bofanglutide (GZR18) Versus Semaglutide in Latin American Adults With Overweight or Obesity (NCT07622810) | Carnot Laboratories | 2026-09-01 |
| A Phase III Study to Evaluate the Effect of Balcinrenone/Dapagliflozin in Patients With CKD Stage 3b and 4 (BalanceD-CKD) (NCT07624305) | AstraZeneca | 2026-09-01 |
| Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD) (NCT07767253) | Sunshine Guojian Pharmaceutical (Shanghai) Co., Ltd. | 2026-09-01 |
| Safety and Efficacy of OTL78 (Zopocianine) (NCT07725523) | Clinton Bahler | 2026-09-01 |
| Pramipexole vs Placebo Treatment in Bipolar Disorder With Anhedonic Depression (NCT07664852) | Daniel Lindqvist | 2026-09-01 |
| A Study to Evaluate the Safety and Efficacy of JZP926 Capsule for the Treatment of Juvenile Myoclonic Epilepsy (NCT07723963) | Jazz Pharmaceuticals | 2026-09-01 |
| A Study to Assess Efficacy and Safety of Adimanebart in Adult and Pediatric Participants With DOK7-,MUSK-, AGRN-, or LRP4- Congenital Myasthenic Syndromes (CMS) (NCT07746089) | argenx | 2026-09-01 |
| Study of Serine Supplementation to Protect Vision in MacTel (NCT07342439) | The Lowy Medical Research Institute Limited | 2026-09-01 |
| Efficacy of Temocillin Compared to Standard of Care in the Treatment of Neisseria Gonorrhoeae Infections (NCT07631364) | Assistance Publique - Hôpitaux de Paris | 2026-09-01 |
| Immunoglobulin Replacement Therapy (IgRT) Versus Antibiotic Prophylaxis (PA) in Patients Treated by CD19-targeted Chimeric Antigen Receptor (CAR)T Cells for a B Cell Acute Lymphoblastic Leukemia or a B Cell Lymphoma (NCT07754682) | Assistance Publique - Hôpitaux de Paris | 2026-09-01 |
| A Study to Evaluate the Efficacy and Safety of Divarasib Compared With Investigator's Choice of Immunotherapy or Observation in Participants With Resected Stage II-III KRAS G12C-Positive Non-Small Cell Lung Cancer (NSCLC) (NCT07541170) | Hoffmann-La Roche | 2026-09-01 |
| Dapagliflozin for Long COVID Syndrome (NCT06907251) | Ottawa Heart Institute Research Corporation | 2026-09-01 |
| Emetine for Viral Outbreaks (a.k.a. EVOLVE Antiviral Initiative) (NCT07016321) | Johns Hopkins University | 2026-09-01 |
| Optimized, Neuroplasticity-Enhanced-Depression (ONE-D) Transcranial Magnetic Stimulation (TMS) Treatment for Female Athletes With Co-morbid Depression and Concussion (NCT07507214) | University of Florida | 2026-09-01 |
| A Study Of Synthetic THC And Sleep (NCT07570953) | Mayo Clinic | 2026-09-01 |
| Efficacy of Intravenous Dexamethasone in Prolonging the Duration of Spinal Anesthesia With Chloroprocaine in Knee Arthroscopy (NCT07674576) | CMC Ambroise Paré | 2026-09-01 |
| Trial of DN022150 Versus Chemotherapy in Previously Treated Advanced Pancreatic Cancer With KRAS G12D Mutation (NCT07689539) | Jiangxi Kvvit Pharmaceutical Co., Ltd. | 2026-09-01 |
| Micronutrient Enhancement for Development and Health in Adolescents - The MEDHA Study (NCT07695883) | Johns Hopkins Bloomberg School of Public Health | 2026-09-01 |
| EBOla Post-Exposure Prophylaxis (NCT06841614) | ANRS, Emerging Infectious Diseases | 2026-09-01 |
| Pediatric Prolonged-Release Melatonin for Sleep Disturbances in Children and Adolescents With Anorexia Nervosa (MELSom-ANOREXIA) (NCT07576764) | Assistance Publique Hopitaux De Marseille | 2026-09-01 |
| APEX-STROKE CALM-ICH Domain (NCT07752719) | Fudan University | 2026-09-01 |
| Migraine Headaches Elimination With Patent Foramen Ovale-Directed Therapy (NCT07629635) | Columbia University | 2026-09-01 |
| Phase III Trial of SGLT2 Inhibitor and Thiazolidinedione Fixed-Dose Combination vs. Monotherapy in Type 2 Diabetes Patients on Metformin (NCT07057479) | Eurofarma Laboratorios S.A. | 2026-09-01 |
| A Trial to Assess the Efficacy and Safety of Engasertib in Participants With Moderate to Severe Hereditary Hemorrhagic Telangiectasia (HHT) (NCT07743671) | Vaderis Therapeutics AG | 2026-09-01 |
| Perioperative Nutrition Optimization for Reducing Complications After Surgical Fracture Fixation (NCT07155447) | University of Minnesota | 2026-09-01 |
| Pivotal Study of N-acetyl-L-leucine for CACNA1A (NCT07221292) | IntraBio Inc | 2026-09-01 |
| STENT X: a Randomized Trial to Assess Stent-free Radical Cystectomy (NCT07655284) | Brigham and Women's Hospital | 2026-09-01 |
| An Investigation of FID 123472 Ophthalmic Solution to Vehicle for the Reduction of Ocular Redness in Adults (NCT07578363) | Alcon Research | 2026-09-01 |
| A Study to Investigate the Efficacy, Pharmacokinetics, and Safety of Mitapivat in Pediatric Participants With Transfusion-Dependent Alpha- or Beta-Thalassemia (α- or β-TDT) (NCT07506863) | Agios Pharmaceuticals, Inc. | 2026-09-01 |
| Outpatient Hypertonic Saline and Loop Diuretic Combination Therapy in Cardiorenal (NCT07596329) | University of Monastir | 2026-09-01 |
| Pre-hepatectomy Rehabilitation in Obese MASLD-Complicated Living Liver Donors With Mazdutide (PRIME) (NCT07718126) | West China Hospital | 2026-09-01 |
| Duo: A Phase IIIb Individual-Level Randomized Controlled Trial of an Integrated Strategy (NCT07658976) | HIV Prevention Trials Network | 2026-09-01 |
| Belantamab Mafodotin or Daratumumab With Bortezomib, Lenalidomide and Dexamethasone for Newly Diagnosed Multiple Myeloma (NCT07285239) | PrECOG, LLC. | 2026-09-01 |
| Efficacy, Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity Study of Ravulizumab in Chinese Adults With Neuromyelitis Optica Spectrum Disorder (NMOSD) (NCT07557420) | Alexion Pharmaceuticals, Inc. | 2026-08-31 |
| Lp(a) Lowering Study of Pelacarsen (TQJ230) in Patients in the US With Elevated Lp(a) and Recent ACS (STEMI/NSTEMI) - Lp(a)FRONTIERS PEARL (NCT07625306) | Novartis Pharmaceuticals | 2026-08-31 |
| Y-6 Sublingual Tablets for Acute Penetrating Artery Infarction (NCT07721545) | Neurodawn Pharmaceutical Co., Ltd. | 2026-08-31 |
| A Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase III Trial of Remestemcel-L-rknd Added to Ruxolitinib for Grade III-IV Steroid-Refractory Acute Graft-Versus-Host Disease (NCT07568535) | Mesoblast, Ltd. | 2026-08-31 |
| Adding Pirtobrutinib to the Usual Treatment for People With Newly Diagnosed Richter Transformation, The PIRAMID Trial (NCT07220187) | SWOG Cancer Research Network | 2026-08-31 |
| Treatment and Secondary Prevention of Venous Thromboembolism (VTE) in Adult Participants With Solid and Hematologic Cancers (NCT07493304) | Regeneron Pharmaceuticals | 2026-08-31 |
| A Study to Assess the Pharmacokinetics, Effectiveness and Safety of Afimkibart for Induction and Maintenance Therapy in Children With Moderately to Severely Active Crohn's Disease (NCT07298421) | Hoffmann-La Roche | 2026-08-31 |
| A Study to Learn About Revaccination With a Vaccine Called RSVpreF in Immunocompromised Adults (NCT07768345) | Pfizer | 2026-08-31 |
| A Phase 3 Study of Efficacy and Safety of AK3280 in Patients With Idiopathic Pulmonary Fibrosis (NCT07719023) | Shanghai Ark Biopharmaceutical Co., Ltd. | 2026-08-31 |
| Study Evaluation Rentosertib (INS018_055) Administered Orally in Patients With Idiopathic Pulmonary Fibrosis (IPF) (NCT07687459) | InSilico Medicine Hong Kong Limited | 2026-08-30 |
| NeoAdjuvant Therapy Comparing Sacituzumab Govitecan+Pembrolizumab vs. SoC Chemotherapy in Clinical Stage II-III, Triple-negative Early Breast Cancer (NCT07178730) | Women's Cancer Study Group GmbH | 2026-08-30 |
| A Study of BGM0504 in Early T2DM With Obesity (NCT07743983) | BrightGene Bio-Medical Technology Co., Ltd. | 2026-08-30 |
| Research Title: Long Term Functional Outcome of a Single Hyaluronic Acid Injection in Improving Symptoms and Function in Patients With Knee Osteoarthritis - A Single-Arm Open-Label Study (DIART ONE). (NCT07736781) | Universiti Sains Malaysia | 2026-08-30 |
| Study of rTMS in Maintenance in Treatment Resistant Depression (NCT07760168) | All India Institute of Medical Sciences, Bhubaneswar | 2026-08-30 |
| Phase II/III Randomized Trial of UC-MSC Secretome vs Sodium Hyaluronate in Knee Osteoarthritis (NCT07337863) | Universitas Sriwijaya | 2026-08-30 |
| A Study to Compare the Efficacy and Safety of BMS-986353 (Zolacabtagene- Autoleucel / Zola-cel), CD19-CAR T Cells, Versus Standard of Care in Participants With Active Systemic Sclerosis (NCT07335562) | Juno Therapeutics, Inc., a Bristol-Myers Squibb Company | 2026-08-29 |
| Testing the Addition of Daratumumab to Chemotherapy for Treating Patients With Newly-Diagnosed T-Cell Lymphoblastic Leukemia (T-ALL) and T-Cell Lymphoblastic Lymphoma (T-LL) (NCT07072585) | Children's Oncology Group | 2026-08-28 |
| FIBRONEER-ACT: A Study to Test Whether Nerandomilast Helps People With Fibrosing Interstitial Lung Disease at Risk for Disease Progression (NCT07540988) | Boehringer Ingelheim | 2026-08-28 |
| A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF (NCT07761117) | AstraZeneca | 2026-08-28 |
| A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease. (NCT07753993) | AstraZeneca | 2026-08-28 |
| A Clinical Trial of MK-8748 Compared to Aflibercept in Participants With Diabetic Macular Edema (MK-8748-004) (NCT07705555) | Merck Sharp & Dohme LLC | 2026-08-28 |
| Study to Assess the Efficacy, Pharmacokinetics, Safety and Tolerability of Atrasentan in Pediatric Patients With Primary IgAN (NCT07498335) | Novartis Pharmaceuticals | 2026-08-26 |
| A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib (NCT07623161) | Takeda | 2026-08-25 |
| Primary Radiotherapy In MEtastatic Lung Cancer (NCT07135882) | Trans Tasman Radiation Oncology Group | 2026-08-25 |
| A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6). (NCT07735637) | AstraZeneca | 2026-08-25 |
| Efficacy and Safety of Roflumilast Foam 0.3% in Trial Participants With Seborrheic Dermatitis (NCT07683806) | Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. | 2026-08-24 |
| A Study to Test Whether Survodutide Helps People With Type 2 Diabetes Control Their Blood Sugar (NCT07754461) | Boehringer Ingelheim | 2026-08-24 |
| A Trial of LBL-024 Combined With Platinum-based Chemotherapy for the Treatment of Advanced EP-NEC (NCT07720193) | Nanjing Leads Biolabs Co.,Ltd | 2026-08-22 |
| A Study to Test the Effects of Centanafadine in Adults With Attention-deficit/Hyperactivity Disorder and Emotional Dysregulation (NCT07759154) | Otsuka Pharmaceutical Development & Commercialization, Inc. | 2026-08-20 |
| Immunogenicity and Safety Study of an Investigational Quadrivalent Meningococcal Conjugate Vaccine Administered in Healthy Infants and Toddlers in China (NCT07710872) | Sanofi | 2026-08-20 |
| Study of Xuanbai Shengmai Decoction in the Treatment of Acute Respiratory Distress Syndrome (NCT07528196) | Southeast University, China | 2026-08-20 |
| Phase 3 Study of Cadonilimab Combined With Chemotherapy vs Chemotherapy in Combination With or Without Nivolumab for the 1L Treatment of Participants With HER2-negative, Previously Untreated, Unresectable or Metastatic Gastric/GEJ Adenocarcinoma (NCT07700979) | Akeso | 2026-08-20 |
| Venous Thromboembolism (VTE) Prophylaxis With REGN7508 and REGN9933 in Adult and Adolescent Participants With a Peripherally Inserted Central Catheter (PICC) (NCT07697599) | Regeneron Pharmaceuticals | 2026-08-20 |
| Safety and Efficacy of HRS-9190 Compared to Rocuronium for Tracheal Intubation and Bolus Maintenance in Adults (NCT07746726) | Jiangsu HengRui Medicine Co., Ltd. | 2026-08-20 |